Frank Takkinen
Lake Street | Healthcare
Frank Takkinen is an analyst from Lake Street specializing in the Healthcare sector. Ranked #1022 out of 4363 analysts, they have issued 18 stock ratings with a success rate of 88.36% and an average return of 23.91%.
With 18 ratings to date, Frank Takkinen is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 88.36% and an average return of 23.91%, highlighting promising potential as their track record develops further.
Recent Ratings Analysis
RCEL
HoldOct 17, 2025
Target
$4.00
Current
$3.99
Performance
0.00%
Frank Takkinen rated RCEL as Hold on Oct 17, 2025, setting a price target of 4. The Hold stance appears justified, as shares hovered around 3.99 with a 0.00% move.
ELUT
BuySep 10, 2025
Target
$6.00
Current
$0.89
Performance
-34.51%
On Sep 10, 2025, ELUT was given a Buy rating by Frank Takkinen, with a target price of 6. Despite the Buy call, shares fell from 0.8907 to 0.8907, challenging the optimistic stance.
HYPR
BuyAug 14, 2025
Target
$2.00
Current
$1.30
Performance
-10.34%
HYPR received a Buy rating from Frank Takkinen on Aug 14, 2025, aiming for 2. The rating hasn’t played out as hoped, with the stock trading 10.34% below expectations.
SGHT
BuyAug 08, 2025
Target
$5.00
Current
$4.69
Performance
10.61%
On Aug 08, 2025, Frank Takkinen published a Buy outlook on SGHT, with a target of 5. Shares gained 10.61%, underscoring the accuracy of the bullish outlook toward 5.
INSP
BuyAug 05, 2025
Target
$150.00
Current
$78.01
Performance
-11.26%
Frank Takkinen on Aug 05, 2025 assigned INSP a Buy rating, with a price target of 150. The call has struggled to gain traction, with shares losing 11.26%.
LUNG
BuyJul 31, 2025
Target
$8.00
Current
$1.52
Performance
-17.39%
On Jul 31, 2025, Frank Takkinen reaffirmed LUNG with a Buy rating, targeting 8. Shares slid 17.39% despite the recommendation, highlighting downside risks.
ANGO
BuyJul 16, 2025
Target
$24.00
Current
$11.54
Performance
34.19%
ANGO was rated Buy by Frank Takkinen on Jul 16, 2025, with a price objective of 24. A bullish response from the market helped close the gap of 12.46 to the target.
CVRX
BuyApr 08, 2025
Target
$14.00
Current
$9.95
Performance
60.48%
On Apr 08, 2025, Frank Takkinen initiated coverage on CVRX with a Buy rating and target of 14. The stock’s climb of 60.48% since the call highlights the foresight in the rating.
LNSR
HoldMar 24, 2025
Target
$15.00
Current
$11.85
Performance
-16.78%
Frank Takkinen issued a Hold recommendation for LNSR on Mar 24, 2025, price target set at 15. Market action validated the conservative Hold outlook with shares at 11.85.
AXGN
BuyMar 17, 2025
Target
$30.00
Current
$16.59
Performance
-9.25%
On Mar 17, 2025, AXGN was evaluated by Frank Takkinen, who gave a Buy rating and target of 30. Investors saw limited payoff as shares fell short of the 30 target.
CLBT
BuyFeb 14, 2025
Target
$26.00
Current
$18.18
Performance
-11.32%
Frank Takkinen rated CLBT as Buy on Feb 14, 2025, setting a price target of 26. The stock has underperformed, dropping 11.32% despite the bullish target of 26.
CLPT
BuyJan 21, 2025
Target
$30.00
Current
$25.38
Performance
37.76%
On Jan 21, 2025, CLPT was given a Buy rating by Frank Takkinen, with a target price of 30. The stock rallied 37.76% after the rating, narrowing the gap to the target of 30 and validating the bullish stance.
KRMD
BuyJan 14, 2025
Target
$5.00
Current
$4.05
Performance
-0.49%
KRMD received a Buy rating from Frank Takkinen on Jan 14, 2025, aiming for 5. Price action was muted, as shares hovered around 4.05 despite the bullish outlook.
AVR
BuyJan 08, 2025
Target
$20.00
Current
$4.87
Performance
-13.50%
On Jan 08, 2025, Frank Takkinen published a Buy outlook on AVR, with a target of 20. Market action contradicted the Buy thesis, as shares slipped to 4.87.
NSPR
BuyDec 11, 2024
Target
$5.00
Current
$2.32
Performance
-26.81%
Frank Takkinen on Dec 11, 2024 assigned NSPR a Buy rating, with a price target of 5. The call has struggled to gain traction, with shares losing 26.81%.
NOTV
BuySep 30, 2024
Target
$4.00
Current
$1.32
Performance
-22.35%
On Sep 30, 2024, Frank Takkinen reaffirmed NOTV with a Buy rating, targeting 4. Shares slid 22.35% despite the recommendation, highlighting downside risks.
AORT
BuyJul 02, 2024
Target
$30.00
Current
$42.08
Performance
64.05%
AORT was rated Buy by Frank Takkinen on Jul 02, 2024, with a price objective of 30. A bullish response from the market helped close the gap of -12.08 to the target.
SILK
HoldJun 18, 2024
Target
$27.50
Current
$27.49
Performance
2.27%
On Jun 18, 2024, Frank Takkinen initiated coverage on SILK with a Hold rating and target of 27.5. The stock’s lack of movement around 27.49 aligned with a cautious approach.